ZPD A/S finalizes KDMF and approval in Korea with its branded Chondroitin Sulfate – ScanDroitin™. The Korean Food and Drug Safety Agency has approved ScanDroitin™ Chondroitin Sulfate as an API with a registered Korean drug master file. ScanDroitin™ is a uniquely manufactured ingredient obtaining the industry’s highest level of purity with a proprietary process which … Read moreZPD A/S finalizes KDMF
ZPD A/S takes measures to ensure stable production during COVID-19 outbreak. Regarding the outbreak of the COVID-19 new coronavirus, ZPD A/S has set up an emergency management system to handle and closely monitor the situation. ZPD A/S has focused on keeping employees and products safe and securing the supply of raw materials and packaging to meet customer … Read moreCOVID-19 Update: Measures taken to ensure stable production
As part of a larger strategic decision to modernize the company image and communication to partners and clients, a new website has been launched.